Madison Wis. - Stratatech Corporation a UW spin-off company has received a $168000 Phase I SBIR Grant from the National Institute on Aging for the development of cell-based gene therapy products for the treatment of chronic skin wounds such as diabetic venous stasis and pressure ulcers which are particularly problematic for the aged popula